Pharma Under Fire, But Firms Serious About Research Will Pay Off, Expert Says

Published: Nov 07, 2016

Pharmaceutical stocks have been under pressure thanks to the public outcry over drug pricing, but certain companies are doing things right, former Medtronic CEO Bill George told CNBC on Friday.

"The ones that are really serious about research, they are going to pay off big time, very big," he said in an interview with "Power Lunch."

Specifically, Merck has the right game plan and names like Amgen and Gilead Sciences have done well, although they've been hit recently, the Harvard Business School senior fellow and CNBC contributor noted.

Back to news